Anticoagulation in Patients with Heart Failure and Sinus Rhythm

The risk of thromboembolic events is significantly increased among patients with heart failure, even in those without atrial fibrillation. However, it is still unclear whether patients with heart failure and sinus rhythm can benefit from prophylactic anticoagulant therapy.This was a retrospective re...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International Heart Journal 2020/11/28, Vol.61(6), pp.1204-1211
Hauptverfasser:	Li, Xiao, Yang, Jingmin, Xu, Danyan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants Anticoagulants - therapeutic use Clinical trials Congestive heart failure Dabigatran Epidemiology Factor Xa Inhibitors - therapeutic use Fibrillation Heart failure Heart Failure - blood Heart Failure - drug therapy Heart Failure - epidemiology Heart Failure - physiopathology Hemorrhage - chemically induced Hemorrhage - epidemiology Humans Rivaroxaban Sinuses Stroke - blood Stroke - epidemiology Stroke - physiopathology Stroke - prevention & control Thromboembolism Thromboembolism - blood Thromboembolism - epidemiology Thromboembolism - physiopathology Thromboembolism - prevention & control Warfarin
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!